Ignite Creation Date:
2024-05-19 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06414018
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-05-10
Brief Title:
Effect of Equivalent Dose Sufentanil and Afentanil in Bronchoscopic Treatment
Sponsor:
Tongji Hospital
Organization:
Tongji Hospital
Study Overview
Official Title:
Effect Observation of Equivalent Dose Sufentanil and Afentanil Combined Laryngeal Mask for Complex Bronchoscopic Treatment
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EOEDSAAIBT
Brief Summary:
The equivalent dose of sufentanil and afentanil combined with laryngeal mask was used for complex bronchoscopy to observe the intraoperative effect and the influence on the recovery of patients
Detailed Description:
Afentanil is a powerful fast-acting narcotic analgesic which can effectively inhibit intubation reflex Compared with sufentanil it has a short half-life and is safer and can be used as the first choice for short surgical analgesics In this study by comparing the use of equivalent dose sufentanil and afentanil combined with laryngeal mask for complex bronchoscopy the intraoperative analgesic effect and the influence on the recovery of patients were observed and a better anesthesia scheme was provided for tracheoscopy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None